Golden State Wealth Management, LLC - Immune Therapeutics Inc ownership

Immune Therapeutics Inc's ticker is IMUN and the CUSIP is 45252A107. A total of 2 filers reported holding Immune Therapeutics Inc in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Golden State Wealth Management, LLC ownership history of Immune Therapeutics Inc
ValueSharesWeighting
Q2 2020$1,00023,0000.00%
Other shareholders
Immune Therapeutics Inc shareholders Q3 2020
NameSharesValueWeighting ↓
MAGNOLIA CAPITAL ADVISORS LLC 23,000$1,0000.00%
MAI Capital Management 12,500$00.00%
Golden State Wealth Management, LLC 23,000$1,0000.00%
View complete list of Immune Therapeutics Inc shareholders